Genus
Website:
Genus
Index:
FTSE 250
EPIC: GNS
Supersector:
Health Care
Sector:
Pharmaceuticals and Biotechnology
Subsector:
Biotechnology
Market Cap:
£1.75B
Payout Frequency: Semi-Annual
Genus Dividend Analysis and Summary
Key Dividend Details
- Dividend type: Interim
- Dividend per share: 11.2p (up +9% vs 10.3p prior interim)
- Record date: 06/03/2026
- Ex-dividend date: 05/03/2026 (derived as one business day before the record date)
- Payment date: 27/03/2026
- Policy framework: Board updated policy to a 30–40% payout of adjusted EPS for the full year; interim set at 35% of the prior full-year dividend (32.0p in FY25 ? 11.2p interim)
- Earnings cover: Rolling 12-month adjusted earnings cover of the dividend at 3.1x (FY25 full-year cover was 2.6x)
Sustainability and Growth Outlook
- Earnings support: H1 adjusted EPS rose to 60.8p (+53%), with adjusted PBT up 57%. This underpins the higher interim.
- Cash and balance sheet: H1 free cash inflow of £8.2m; net debt/adjusted EBITDA improved to 1.4x (ample covenant headroom, facilities to 2029). Cash conversion dipped to 60% due to working capital outflows.
- Near-term cash catalyst: Expected JV proceeds of ~£100m in fiscal Q4 (formation of Chinese porcine JV) should further strengthen liquidity and reduce leverage, supporting dividend capacity.
- Policy clarity: The 30–40% adjusted EPS payout range and formulaic interim (35% of prior full-year dividend) provide visibility and smoothing. Given rolling 12-month adjusted EPS and improving cover, the progressive trajectory looks maintainable absent a sharp earnings or cash downturn.
Structural/Policy Changes Relevant to Dividends
- Dividend policy update: Explicit 30–40% payout of adjusted EPS; interim fixed at 35% of prior full-year. This formalises a progressive approach and should reduce interim volatility.
- China porcine JV and deconsolidation: JV with BCA completed on 31 Jan 2026; PIC China will be deconsolidated and Genus expects ~£100m cash in Q4. While reported revenues/profits from PIC China move to equity-accounted, the upfront cash and potentially lower volatility are supportive of future distributions.
- ABS Value Acceleration Programme (VAP): Ongoing restructuring delivering profit benefits but with exceptional cash costs; medium-term margin and cash improvements in bovine should aid dividend sustainability once restructuring completes.
Risks and Flags to Dividend Stability
- Cash conversion and working capital: H1 cash conversion fell to 60% with a working capital outflow; sustained improvement is desirable for dividend resilience.
- One-off/exceptional items: Continued VAP-related exceptional cash costs could temporarily weigh on free cash flow.
- Regulatory/commercial timing: PRRS-resistant pig (PRP) still awaiting approvals in key export markets; commercialisation timing remains a risk to projected growth.
- Geopolitical/trade: Ongoing China import restrictions on U.S. bovine genetics impact ABS Asia; broader biosecurity and trade risks persist.
- Russia exposure: Sanctions-related constraints remain; a potential deconsolidation of Russian entities in adverse scenarios could lead to an impairment (previously flagged up to ~£20m) and reduce reported earnings.
Read more
Genus Annual Dividend Yield - 1.2%
Dividends Used in Calculation:
| Ex-Dividend Date |
Payment Date |
Type |
Amount |
Currency |
| 06/03/2025 |
04/04/2025 |
Interim |
10.30p |
GBX |
| 06/11/2025 |
05/12/2025 |
Final |
21.70p |
GBX |
Total (Annual Dividends Per Share):
32.00p
Dividend Yield =
Annual Dividends Per Share (32.00p)
÷ Share Price (2675p)
= 1.2%
Genus Dividend History
| Ex Dividend Date |
Payment Date |
Type |
Amount |
Currency |
| 05/03/2026 |
27/03/2026 |
Interim |
11.2000p |
GBX |
| 06/11/2025 |
05/12/2025 |
Final |
21.70p |
GBX |
| 06/03/2025 |
04/04/2025 |
Interim |
10.30p |
GBX |
| 07/11/2024 |
06/12/2024 |
Final |
21.70p |
GBX |
| 29/02/2024 |
28/03/2024 |
Interim |
10.30p |
GBX |
| 09/11/2023 |
08/12/2023 |
Final |
21.70p |
GBX |
| 02/03/2023 |
30/03/2023 |
Interim |
10.30p |
GBX |
| 17/11/2022 |
09/12/2022 |
Final |
21.70p |
GBX |
| 03/03/2022 |
31/03/2022 |
Interim |
10.30p |
GBX |
| 18/11/2021 |
10/12/2021 |
Final |
21.70p |
GBX |
| 04/03/2021 |
01/04/2021 |
Interim |
10.30p |
GBX |
| 19/11/2020 |
11/12/2020 |
Final |
19.70p |
GBX |
| 05/03/2020 |
02/04/2020 |
Interim |
9.40p |
GBX |
| 07/11/2019 |
29/11/2019 |
Final |
18.80p |
GBX |
| 07/03/2019 |
04/04/2019 |
Interim |
8.90p |
GBX |
| 15/11/2018 |
30/11/2018 |
Final |
17.90p |
GBX |
| 08/03/2018 |
04/04/2018 |
Interim |
8.10p |
GBX |
| 16/11/2017 |
01/12/2017 |
Final |
16.20p |
GBX |
| 02/03/2017 |
31/03/2017 |
Interim |
7.40p |
GBX |
| 17/11/2016 |
02/12/2016 |
Final |
14.70p |
GBX |
| 03/03/2016 |
30/03/2016 |
Interim |
6.70p |
GBX |
| 19/11/2015 |
04/12/2015 |
Final |
13.40p |
GBX |
| 05/03/2015 |
27/03/2015 |
Interim |
6.10p |
GBX |
| 20/11/2014 |
05/12/2014 |
Final |
12.20p |
GBX |
| 05/03/2014 |
28/03/2014 |
Interim |
5.50p |
GBX |
| 16/11/2013 |
06/12/2013 |
Final |
11.10p |
GBX |
| 13/03/2013 |
08/04/2013 |
Interim |
5.00p |
GBX |
| Year |
Interim |
Final |
Currency |
Total |
Change |
| 2024 |
10.300 |
21.700 |
GBX |
32.000 |
0.000 |
| 2023 |
10.300 |
21.700 |
GBX |
32.000 |
0.000 |
| 2022 |
10.300 |
21.700 |
GBX |
32.000 |
0.000 |
| 2021 |
10.300 |
21.700 |
GBX |
32.000 |
9.960 |
| 2020 |
9.400 |
19.700 |
GBX |
29.100 |
5.050 |
| 2019 |
8.900 |
18.800 |
GBX |
27.700 |
6.530 |
| 2018 |
8.100 |
17.900 |
GBX |
26.000 |
10.160 |
| 2017 |
7.400 |
16.200 |
GBX |
23.600 |
10.280 |
| 2016 |
6.700 |
14.700 |
GBX |
21.400 |
9.740 |
| 2015 |
6.100 |
13.400 |
GBX |
19.500 |
10.160 |
| 2014 |
5.500 |
12.200 |
GBX |
17.700 |
9.930 |
| 2013 |
5.000 |
11.100 |
GBX |
16.100 |
|
Genus Dividend Calculator
Genus Dividend Growth
| Dividend Growth (1Y) |
2.81%
|
| Dividend CAGR (5Y) |
1.86%
|
| Years of Growth |
–
|
| Payout Ratio |
44.42%
|
| Buyback Yield |
-2.04%
|
| Shareholder Yield |
-0.84%
|
| P/E Ratio (TTM) | 37.2 |
| Forward P/E | 25.28 |
| P/FCF | 34.64 |
| Earnings Yield | 2.69% |
| FCF Yield | 2.89% |
| ROE | 9.35% |
| ROCE | 10.5% |
| Profit Margin | 7.07% |
| Operating Margin | 12.29% |
| Gross Margin | 40.12% |